Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BIIB · against 1,216 other Healthcare companies
Ranked #968 of 1,217 · scores higher than 20% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 20–29, including BIIB · Click a bar to see the companies
Mainly because of its earnings per share growth, 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | BIIB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 0.3% | 6.1% | 32% | 33% | |
| Earnings per share growthHigher is better · 682 reported | -45.9% | 9.7% | 12% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 0.2% | 5.8% | 29% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 968 | 12.3B TWD (≈$381M) | 20 | 67 | |
| 968 | 9.6B CNY (≈$1.3B) | 20 | 27 | |
| 968 | 3.0B CNY (≈$415M) | 20 | 55 | |
| 968 | 1.0B MYR (≈$229M) | 20 | 44 | |
| 968 | 36.8B USD | 20 | 46 | |
| 968 | 22.3B SEK (≈$2.2B) | 20 | 36 | |
| 968 | 1.91T IDR (≈$119M) | 20 | 26 | |
| 968 | 356.9B USD | 20 | 37 | |
| 968 | 66.3B USD | 20 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score